Inflammation in high-grade carotid stenosis: A possible role for macrophages and T cells in plaque destabilization

Stroke

Volumn 29, Issue 8, 1998, Pages 1625-1630

  Jander, Sebastian ^a   Sitzer, Matthias ^a   Schumann, René ^a   Schroeter, Michael ^a   Siebler, Mario ^a   Steinmetz, Helmuth ^a   Stoll, Guido ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Atherosclerosis; Carotid arteries; Cerebrovascular disorders immunohistochemistry; Leukocytes

Indexed keywords

CD3 ANTIGEN; CD68 ANTIGEN;

ADULT; AGED; ARTICLE; ATHEROSCLEROTIC PLAQUE; BRAIN EMBOLISM; CAROTID ARTERY OBSTRUCTION; CAROTID ENDARTERECTOMY; CELL INFILTRATION; CLINICAL ARTICLE; DOPPLER ECHOGRAPHY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; INFLAMMATION; INTERNAL CAROTID ARTERY; MACROPHAGE; MALE; MICROEMBOLISM; PATHOGENESIS; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0031881001     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.29.8.1625     Document Type: Article

References (45)

1. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990's. Nature. 1993;362:801-809.
2. Gown AM, Tsukada T, Ross R. Human atherosclerosis, II: immunocytochemical analysis of the cellular composition of human atherosclerotic lesions. Am J Pathol. 1986;125:191-207.
3. Jonasson L, Holm J, Skalli O, Bondjers G, Hansson GK. Regional accumulations of T cells, macrophages and smooth muscle cells in the human atherosclerotic plaque. Arteriosclerosis. 1986;6:131-138.
4. van der Wal AC, Das PK, Benz van de Berg D, van der Loos CM, Becker AE. Atherosclerotic lesions in humans: in situ immunophenotypic analysis suggesting an immune mediated response. Lab Invest. 1989;61: 166-170.
5. Kaartinen M, Penttila A, Kovanen PT. Mast cells in rupture-prone areas of human coronary atheromas produce and store TNF-alpha. Circulation. 1996;94:2787-2792.
6. Henney AM, Wakely PR, Davies MJ, Foster K, Hembry R, Murphy G, Humphries S. Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization. Proc Natl Acad Sci U S A. 1991;88:8154-8158.
7. Galis ZS, Sukhova GK, Lark MW, Libby P. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest. 1994;94: 2493-2503.
8. Wilcox JN, Smith KM, Schwartz SM, Gordon D. Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc Natl Acad Sci U S A. 1989;86:2839-2843.
9. Moreno PR, Bernardi VH, López-Cuéllar J, Muria AM, Palacios IF, Gold HK, Mehran R, Sharma SK, Nemerson Y, Fuster V, Fallon JT. Macrophages, smooth muscle cells, and tissue factor in unstable angina: implications for cell-mediated thrombogenicity in acute coronary syndromes. Circulation. 1996;94:3090-3097.
10. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes (1). N Engl J Med. 1992;326:242-250.
11. Pessin MS, Hinton RC, Davis KR, Duncan GW, Roberson GH, Ackermann RH, Mohr JP. Mechanisms of acute carotid stroke. Ann Neurol. 1979;6:245-252.
12. Fieschi C, Argentino C, Lenzi GL, Sacchetti ML, Toni D, Bozzao L. Clinical and instrumental evaluation of patients with ischemic stroke within the first six hours. J Neurol Sci. 1989;91:311-321.
13. Hennerici M, Hülsbömer H-B, Hefter H, Lammerts D, Rautenberg W. Natural history of asymptomatic extracranial arterial disease. Brain. 1987;110:777-791.
14. North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med. 1991;325: 445-453.
15. European Carotid Surgery Trialists Collaborative Group. MRC European Carotid Surgery Trial: interim results for symptomatic patients with severe (70-99%) or with mild (0-29%) carotid stenosis. Lancet. 1991; 337:1235-1243.
16. Spencer MP, Thomas GI, Nicholls SC, Sauvage LR. Detection of middle cerebral artery emboli during carotid endarterectomy using transcranial Doppler ultrasonography. Stroke. 1990;21:415-423.
17. Siebler M, Kleinschmidt A, Sitzer M, Steinmetz H, Freund H-J. Cerebral microembolism in symptomatic and asymptomatic high-grade internal carotid artery stenosis. Neurology. 1994;44:615-618.
18. Siebler M, Nachtmann A, Sitzer M, Rose G, Kleinschmidt A, Rademacher J, Steinmetz H. Cerebral microembolism and the risk of ischemia in asymptomatic high-grade internal carotid artery stenosis. Stroke. 1995;26:2184-2186.
19. Siebler M, Sitzer M, Rose G, Bendfeldt D, Steinmetz H. Silent cerebral embolism caused by neurologically symptomatic high-grade carotid stenosis: event rates before and after carotid endarterectomy. Brain. 1993; 116:1005-1015.
20. van Zuilen EV, Moll FL, Vermeulen FE, Mauser HW, van Gijn J, Ackerstaff RG. Detection of cerebral microemboli by means of transcranial Doppler monitoring before and after carotid endarterectomy. Stroke. 1995;26:210-213.
21. Sitzer M, Müller W, Siebler M, Hort W, Kniemeyer H-W. Jäncke L, Steinmetz H. Plaque ulceration and lumen thrombus are the main sources of cerebral microemboli in high-grade internal carotid artery stenosis. Stroke. 1995;26:1231-1233.
22. Spencer MP. Doppler microembolic signals for diagnosis of ulcerated carotid artery plaques. Echocardiography. 1996;13:551-554.
23. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. Endarterectomy for asymptomatic carotid artery stenosis. JAMA. 1995;273:1421-1428.
24. North American Symptomatic Carotid Endarterectomy Trial (NASCET) Steering Committee. North American Symptomatic Carotid Endarterectomy Trial: methods, patient characteristics, and progress. Stroke. 1991; 22:711-720.
25. Consensus Committee of the Ninth International Cerebral Hemodynamic Symposium. Basic identification criteria of Doppler microembolic signals. Stroke. 1995;26:1123.
26. Markus HS, Ackerstaff R, Babikian V, Bladin C, Droste D, Grosset D, Levi C, Russell D, Siebler M, Tegeler C. Intercenter agreement in reading Doppler embolic signals: a multicenter international study. Stroke. 1997; 28:1307-1310.
27. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurements. Lancet. 1986;1:307-310.
28. Holm S. A simple sequentially rejective multiple test procedure. Scand J Stat. 1979;6:65-70.
29. Davies MJ, Richardson PD, Woolf N, Katz DR, Mann J. Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content. Br Heart J. 1993;69: 377-381.
30. Moreno PR, Falk E, Palacios IF, Newell JB, Fuster V, Fallon JT. Macrophage infiltration in acute coronary syndromes: implications for plaque rupture. Circulation. 1994;90:775-778.
31. van der Wal AC, Becker AE, van der Loos CM, Das PK. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation. 1994;89:36-44.
32. Hansson GK, Libby P. The role of the lymphocyte. In: Fuster V, Ross R, Topol EJ, eds. Atherosclerosis and Coronary Artery Disease. Philadelphia, Pa: Lippincott-Raven Publishers; 1996:557-568.
33. Raines EW, Rosenfeld ME, Ross R. The role of macrophages. In: Fuster V, Ross R, Topol EJ, eds. Atherosclerosis and Coronary Artery Disease. Philadelphia, Pa: Lippincott-Raven Publishers: 1996:539-555.
34. Neri Serneri GG, Abbate R, Gori AM, Attanasio M, Martini F, Giusti B, Dabizzi P, Poggesi L, Modesti PA, Trotta F, Rostagno C, Boddi M, Gensini GF. Transient intermittent lymphocyte activation is responsible for the instability of angina. Circulation. 1992;86:790-797.
35. Hansson GK, Holm J, Jonasson L. Detection of activated T lymphocytes in the human atherosclerotic plaque. Am J Pathol. 1989;135:169-175.
36. Stemme S, Holm J, Hansson GK. T lymphocytes in human atherosclerotic plaques are memory cells expressing CD45RO and the integnn VLA-1. Arterioscler Thromb. 1992;12:206-211.
37. Stemme S, Faber B, Holm J, Wiklund O, Witztum JL, Hansson GK. T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein. Proc Natl Acad Sci U S A. 1995;92:3893-3897.
38. + T cells infiltrate lesions of apolipoprotein-E-deficient mice. Am J Pathol. 1996;149:359-366.
39. Del Prete G, De Carli M, Lammel RM, D'Elios MM, Daniel KC, Giusti B, Abbate R, Romagnani S. Th1 and Th2 T-helper cells exert opposite regulatory effects on procoagulant activity and tissue factor production by human monocytes. Blood. 1995;86:250-257.
40. Masawa N, Yoshida Y, Yamada T, Joshita T, Sato S, Mihara B. Three-dimensional analysis of human carotid atherosclerotic ulcer associated with recent thrombotic occlusion. Pathol Int. 1994;44:745-752.
41. Carr S, Farb A, Pearce WH, Virmani R, Yao JS. Atherosclerotic plaque rupture in symptomatic carotid artery stenosis. J Vasc Surg. 1996;23: 755-765.
42. Carr S, Farb A., Pearce WH, Virmani R, Yao JS. Activated inflammatory cells are associated with plaque rupture in carotid artery stenosis. Surgery. 1997;122:757-764.
43. Farb A, Burke AP, Tang AL, Liang Y, Mannan P, Smialek J, Virmani R. Coronary plaque erosion without rupture into a lipid core: a frequent cause of coronary thrombosis in sudden coronary death. Circulation. 1996;93:1354-1363.
44. Casscells W, Hathorn B, David M, Krabach T, Vaughn WK, McAllister HA, Bearman G, Willerson JT. Thermal detection of cellular infiltrates in living atherosclerotic plaques: possible implications for plaque rupture and thrombosis. Lancet. 1996;347:1447-1449.
45. Vallabhajosula S, Fuster V. Atherosclerosis: imaging techniques and the evolving role of nuclear medicine. J Nucl Med. 1997;38:1788-1796.